Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis

详细信息    查看全文

• 作者：Heidi W. Thermenos^a ; ^b ; ^c ; ^{hthermen@bidmc.harvard.edu" class="auth_mail" title="E-mail the corresponding author} ; Richard J. Juelich^a ; ^d ; Samantha R. DiChiara^a ; ^c ; Raquelle I. Mesholam-Gately^a ; ^b ; Kristen A. Woodberry^a ; ^b ; Joanne Wojcik^a ; ^b ; Nikos Makris^c ; Matcheri S. Keshavan^a ; ^b ; Susan Whitfield-Gabrieli^e ; Tsung-Ung W. Woo^a ; ^b ; ^f ; Tracey L. Petryshen^a ; ^c ; Jill M. Goldstein^a ; ^g ; Martha E. Shenton^a ; ^h ; ⁱ ; Robert W. McCarley^a ; ^h ; ⁱ ; Larry J. Seidman^a ; ^b ; ^c
• 关键词：Psychosis ; Prodrome ; fMRI ; Clinical high risk ; Working memory
• 刊名：Schizophrenia Research
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：173
• 期：1-2
• 页码：1-12
• 全文大小：788 K

文摘

Deficits in working memory (WM) are a core feature of schizophrenia (SZ) and other psychotic disorders. We examined brain activity during WM in persons at clinical high risk (CHR) for psychosis.

Methods

Thirty-seven CHR and 34 healthy control participants underwent functional MRI (fMRI) on a 3.0 T scanner while performing an N-back WM task. The sample included a sub-sample of CHR participants who had no lifetime history of treatment with psychotropic medications (n = 11). Data were analyzed using SPM8 (2-back > 0-back contrast). Pearson correlations between brain activity, symptoms, and WM performance were examined.

Results

The total CHR group and medication-naive CHR sub-sample were comparable to controls in most demographic features and in N-back WM performance, but had significantly lower IQ. Relative to controls, medication-naïve CHR showed hyperactivity in the left parahippocampus (PHP) and the left caudate during performance of the N-back WM task. Relative to medication-exposed CHR, medication naïve CHR exhibited hyperactivity in the left caudate and the right dorsolateral prefrontal cortex (DLPFC). DLPFC activity was significantly negatively correlated with WM performance. PHP, caudate and DLPFC activity correlated strongly with symptoms, but results did not withstand FDR-correction for multiple comparisons. When all CHR participants were combined (regardless of medication status), only trend-level PHP hyperactivity was observed in CHR relative to controls.

Conclusions

Medication-naïve CHR exhibit hyperactivity in regions that subserve WM. These regions are implicated in studies of schizophrenia and risk for psychosis. Results emphasize the importance of medication status in the interpretation of task - induced brain activity.